When it came to the study’s secondary endpoints of survival, Telix pointed to a median overall survival (OS) rate of 12.4 ...

TLX101 therapy was efficacious in recurrent high-grade glioma, a type of brain cancer, according to preliminary results from ...

these researchers report 5-year outcomes for 901 men who underwent prostatectomy and 286 who received external beam radiotherapy, but who were otherwise similar clinically and demographically.

Telix Pharmaceuticals Ltd.’s glioblastoma theranostic, TLX-101, is showing promising overall survival in a phase II trial in recurrent high-grade glioma. The targeted radiation therapy, combined with ...

LONG ISLAND, NY — Northwell Cancer Institute’s radiation therapy centers in Greenlawn and Lake Success became the first on ...

MARTINSBURG, WV — WVU Medicine Berkeley Medical Center is now offering a new treatment for liver cancer, according to a ...

This is in combination with external beam radiation therapy, to patients with first or second recurrence of the disease. As ...